Study reveals HIV, Hepatitis B drugs could significantly cut Alzheimer’s risk
HQ Team May12, 2025: A new study has uncovered a link between widely used antiviral medications and a dramatically reduced risk of Alzheimer’s.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team May12, 2025: A new study has uncovered a link between widely used antiviral medications and a dramatically reduced risk of Alzheimer’s.
Biogen Inc. and its Japanese partner, Eisai Co. Ltd., announced that the US regulator had approved four-weekly maintenance dosing for its Alzheimer's drug.
August 19, 2024: Alzheimer’s is the most common form of dementia, but there is no known cure for the disease yet, though medicines.
HQ Team June 27, 2024: A new study has found that the removal of both ovaries can have long-term health consequences The US.
Roche, a Swiss drugmaker, announced its Alzheimer's drug did not meet the primary goal of slowing the disease during two clinical trials
Japanese scientists develop method to detect alzheimer's in blood by measuring amyloid β build up.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com